LPAR3 and cancer: ,14,15,16,17 Indeed, a landscape of GPCR-centric autocrine, paracrine, juxtacrine, or endocrine signaling networks is emerging as a critical component for the interaction of cancer cells with their tumor micro-environment (TME), ultimately leading to cancer progression and therapy resistance.15